Status:
COMPLETED
Glycemic Response to Wild Rice and Wild Rice Blends in Humans Study
Lead Sponsor:
University of Manitoba
Collaborating Sponsors:
Mitacs
Conditions:
Blood Glucose
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to test the effects of wild rice and wild rice blends compared to other rice on glycemic control and evaluating factors that influence glycemic response to wild rice...
Detailed Description
This study will be a crossover randomized trial consisting of 5 sessions. The wild rice products will be provided by the Myera group. Participants will fast and arrive at the Richardson Centre for Fo...
Eligibility Criteria
Inclusion
- Participant is willing and able to give informed consent for participation in the trial
- Male or female between 18-50 years old
- BMI range in between 18.9-29.9 kg/m2
- Fasting glucose \<5.6 mmol/L
- Usually eat breakfast
- Participant must receive at least two doses of COVID-19 vaccine that have been recognized by Winnipeg Regional Health Authorities.
- In the Investigator's opinion is able and willing to comply with all trial requirements
Exclusion
- Fasting glucose ≥ 5.6 mmol/L or \<3.5 mmol/L
- Female participant who is pregnant, lactating or planning pregnancy during the course of the trial
- Participants who indicate that they could not finish study treatments within 10 minutes
- Use of medication or supplements that may influence carbohydrate metabolism, including, not limit to adrenergic blockers, diuretics, thiazolidinediones, metformin and systemic corticosteroids within 4 weeks of screening visit
- History of disordered eating, AIDS, hepatitis, a history of clinically important endocrine (including Type I and Type II diabetes mellitus), cardiovascular (including but not limit to atherosclerotic disease, history of myocardial infarction, peripheral arterial disease, stroke), pulmonary, biliary or GI disorders
- Intolerance or allergic reaction to rice
- Existing restrictive dietary habits (such a vegan, low carbohydrate/keto)
- History of hypertension
- History of cancer within the last two years (except for non-melanoma skin cancer)
- Recent history (within 12 month of screening) or current consumption of \>14 drinks per week, (1 drink = 12oz of beer, 5oz of wine or 1.5oz distilled spirits)
- Body weight change over 3.5kg for the past 3 months
- Participants who have participated in another research trial involving an investigational product in the past 12 weeks
- Had significant physical trauma or major surgery in the past 3 month or had trauma or major surgery in the past 3 months
Key Trial Info
Start Date :
July 14 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 29 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05976633
Start Date
July 14 2023
End Date
February 29 2024
Last Update
October 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Richardson Center for Food Technology and Research
Winnipeg, Manitoba, Canada, R3T 2N2